2025-07-10 - Analysis Report
Okay, here's a report analyzing SDGR (Schrodinger Inc) based on the data you provided.

## SDGR (Schrodinger Inc) Analysis Report

**Schrodinger Inc. is a company that develops software for drug discovery and materials science.**

### 1. Performance vs. S&P 500 (VOO)

*   **Key Metrics:**
    *   SDGR Cumulative Return: -50.77%
    *   VOO Cumulative Return: 51.04%
    *   Absolute Divergence: -103.4%
    *   Relative Divergence: 0.0
    *   Divergence Range: Max 66.2, Min -103.4

*   **Analysis:** SDGR has significantly underperformed the S&P 500 (VOO). The absolute divergence is -103.4%, indicating a substantial difference in cumulative returns. The relative divergence of 0.0 suggests that SDGR is currently at the lower end of its historical divergence range compared to VOO.

**Alpha, Beta Analysis**

| Year        | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
| ----------- | ------ | ------ | ------ | ---- | ------ |
| 2020-2022   | -74.0% | 68.9%  | -89.0% | -0.1 | 1.4    |
| 2021-2023   | -65.0% | 68.9%  | -83.0% | -0.0 | 2.6    |
| 2022-2024   | 8.0%  | 72.4%  | -17.0% | -0.0 | 1.4    |
| 2023-2025   | 3.0%  | 74.0%  | -44.0% | -0.0 | 1.6    |

*   **Analysis:**
    *   **CAGR:**  Shows negative returns for most periods, indicating poor performance.  The most recent period (2023-2025) shows a slight positive CAGR.
    *   **MDD:** High Maximum Drawdown (MDD) values suggest significant volatility and potential risk.
    *   **Alpha:** Consistently negative Alpha values indicate underperformance relative to the market, even considering risk.
    *   **Beta:**  Beta values close to zero suggest SDGR's price movements are not strongly correlated with the S&P 500.
    *   **Cap(B):** Market Capitalization has fluctuated.

### 2. Recent Price Action

*   **Key Metrics:**
    *   Current Price: 21.89
    *   Last Market Data: Price: 21.84, Previous Close: 21.42, Change: 1.96%
    *   5-day Moving Average: 21.04
    *   20-day Moving Average: 21.70
    *   60-day Moving Average: 23.16

*   **Analysis:** The current price is slightly above the 5-day and 20-day moving averages but below the 60-day moving average. The 1.96% change from the previous close suggests a recent upward price movement.

### 3. Market Risk Indicators & Expected Return

*   **Key Metrics:**
    *   Market Risk Indicator (MRI): 0.34 (Low Risk)
    *   RSI: 57.03
    *   PPO: 0.41
    *   Hybrid Signal: cash_14%_Buy 80% of cash (843 shares - Caution - MRI:0.34)
    *   Recent (20-day) Relative Divergence Change: 0.0 (Negative)
    *   Expected Return: -5613.1%

*   **Analysis:**
    *   **MRI:** The MRI of 0.34 suggests a low-risk environment.
    *   **RSI:** An RSI of 57.03 is neutral, not indicating overbought or oversold conditions.
    *   **PPO:** The PPO is positive, suggesting a slight upward trend.
    *   **Hybrid Signal:** The hybrid signal recommends a cautious approach, advising to buy 80% of available cash with a cash ratio of 14%.
    *   **Relative Divergence Change:** The change is 0.0, indicating short-term decline
    *   **Expected Return:** The extremely negative expected return (-5613.1%) suggests significant potential underperformance compared to the S&P 500 in the long term.
    *   **Price change:**  The price change of 1.96% is a notable increase, suggesting some positive momentum in the short term.

### 4. Recent News & Significant Events

*   **Summary:** Recent news indicates potential business developments, regulatory changes, and market events impacting SDGR. Analysts are discussing the company's performance in the context of industry trends and economic factors. The stock has shown notable volatility, and market experts advise monitoring news and announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출     |
| ---------- | ----- | -------- |
| 2025-05-07 | -0.82 | 0.06 B$  |
| 2024-11-12 | -0.52 | 0.04 B$  |
| 2024-07-31 | -0.74 | 0.05 B$  |
| 2024-05-01 | -0.76 | 0.04 B$  |
| 2025-05-07 | -0.76 | 0.04 B$  |

*   **Analysis:**
    *   **EPS:** Consistently negative Earnings Per Share (EPS) indicates that the company is not currently profitable.
    *   **Revenue:** Revenue figures are relatively stable but low.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-03-31 | $0.06B  | 52.26%        |
| 2024-12-31 | $0.09B  | 72.61%        |
| 2024-09-30 | $0.04B  | 50.24%        |
| 2024-06-30 | $0.05B  | 66.20%        |
| 2024-03-31 | $0.04B  | 51.61%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE       |
| ---------- | ------- | --------- |
| 2025-03-31 | $0.37B  | -16.01%   |
| 2024-12-31 | $0.42B  | -9.54%    |
| 2024-09-30 | $0.45B  | -8.49%    |
| 2024-06-30 | $0.47B  | -11.40%   |
| 2024-03-31 | $0.51B  | -10.65%   |

*   **Analysis:**
    *   **Revenue:**  Revenue fluctuates but generally remains low.
    *   **Profit Margin:** Positive profit margins indicate that the company is generating profit from its sales, although not enough to offset operating expenses.
    *   **Equity:** Equity has been decreasing, suggesting potential financial strain.
    *   **ROE:** Negative Return on Equity (ROE) reflects the company's inability to generate profits from shareholder equity.

### 7. Overall Analysis & Conclusion

Based on the provided data, SDGR is facing significant challenges. It has underperformed the S&P 500, exhibits high volatility, and is currently unprofitable. While recent news suggests potential developments, the negative expected return and declining equity raise concerns about its long-term financial health. The hybrid signal suggests caution, and investors should carefully monitor the company's performance and announcements before making any investment decisions. The recent price increase is a positive sign but should be considered within the context of the overall negative trend.

In summary:

*   **Negative Points:**
    *   Significant underperformance vs. S&P 500.
    *   Negative Alpha, negative ROE, negative EPS
    *   High Volatility (MDD)
    *   Negative expected return
    *   Declining Equity

*   **Positive Points:**
    *   Positive Profit Margins
    *   Recent price increase
    *   Low Risk MRI
